Showing results (101-110 of 177) with videos related to

Sort By:
Pageof 18
JAMA Oncology|October 28, 2017
Association of 70-Gene Signature Assay Findings With Physicians' Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene AssayMichaela Tsai, Shelly Lo, William Audeh, et al.
Cancer Medicine|August 9, 2022
Behavioral beliefs about genetic counseling among high-risk Latina breast cancer survivors in Florida and Puerto RicoJessica N Rivera Rivera, Claire C Conley, Eida M Castro-Figueroa, et al.
Translational Behavioral Medicine|October 7, 2022
Provider discussion of genetic counseling among high-risk Spanish-preferring Latina breast cancer survivorsClaire C Conley, Jessica N Rivera Rivera, Eida M Castro-Figueroa, et al.
Cancer Medicine|June 24, 2021
A mixed-methods study of cyclin-dependent kinase 4 and 6 inhibitor symptom burden and quality of life among metastatic breast cancer patients and providersLaura B Oswald, Brandy Arredondo, Mika Kadono, et al.
Cell Reports. Medicine|May 7, 2026
Taxane chemotherapy promotes response to TIM-3 checkpoint blockade via STING-mediated ER stress and HMGB1 secretionAlexis Onimus, Daiana Celias, Shiun Chang, et al.
European Heart Journal. Cardiovascular Imaging|September 12, 2022
EACVI survey on the multi-modality imaging assessment of the right heartHatem Soliman-Aboumarie, Shruti S Joshi, Matteo Cameli, et al.
Investigational New Drugs|May 22, 2026
A phase 1 study of PF-07260437, a B7-H4 × CD3 bispecific T-cell engager, in patients with advanced or metastatic breast, ovarian, and endometrial cancerFengting Yan, Marcia Cruz-Correa, Jennifer Specht, et al.
Cancer Immunology, Immunotherapy : CII|January 25, 2013
Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistryHatem Soliman, Bhupendra Rawal, Jimmy Fulp, et al.
Clinical Imaging|September 13, 2025
Quantitative habitat concentration analysis of triple negative breast cancer on MRI correlates with pathologic response to combination neoadjuvant immuno/chemotherapyR Jared Weinfurtner, Dana Ataya, Kimberly Funaro, et al.
BMC Cancer|February 2, 2020
MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trialHatem Soliman, Varsha Shah, Gordan Srkalovic, et al.
Pageof 18